Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes

Completed · Phase 3

Conditions studied: Diabetes, Diabetes Mellitus, Type 2

In brief

This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to test if Insulin Detemir as add-on to current Oral Antidiabetic Drug treatment is at least as effective as Insulin Glargine as add-on to current Oral Antidiabetic Drug treatment in reducing HbA1c in patients with Type 2 Diabetes.

Key facts

Study ID

NCT00283751

Run by

Novo Nordisk A/S

People needed

583

Starts

2003-03-01

Expected to finish

2004-11-01

Last updated by the study team

2017-01-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 Diabetes for more than 12 months, and no previous insulin treatment
• Oral Antidiabetic Drug treatment for at least 4 months
• Body Mass Index (BMI) less than 40 kg/m2
• HbA1c 7.5-10.0%

You may not qualify if…

• Current or previous treatment with thiazolidinediones within the last 6 months
• Oral Antidiabetic Drug treatment with combination of three or more Oral Antidiabetic Drugs within the last 6 months
• Proliferative retinopathy or maculopathy
• Known hypoglycaemia unawareness

Where it is running

• Novo Nordisk Investigational Site — La Mesa, California, United States
• Novo Nordisk Investigational Site — West Palm Beach, Florida, United States
• Novo Nordisk Investigational Site — Atlanta, Georgia, United States
• Novo Nordisk Investigational Site — Chicago, Illinois, United States
• Novo Nordisk Investigational Site — Springfield, Illinois, United States
• Novo Nordisk Investigational Site — Topeka, Kansas, United States
• Novo Nordisk Investigational Site — Chesterfield, Missouri, United States
• Novo Nordisk Investigational Site — St Louis, Missouri, United States
• Novo Nordisk Investigational Site — Lincoln, Nebraska, United States
• Novo Nordisk Investigational Site — Pleasantville, New Jersey, United States
• Novo Nordisk Investigational Site — Cleveland, Ohio, United States
• Novo Nordisk Investigational Site — Kettering, Ohio, United States
• Novo Nordisk Investigational Site — Philadelphia, Pennsylvania, United States
• Novo Nordisk Investigational Site — Mt. Pleasant, South Carolina, United States
• Novo Nordisk Investigational Site — Dallas, Texas, United States
• Novo Nordisk Investigational Site — Dallas, Texas, United States
• Novo Nordisk Investigational Site — Dallas, Texas, United States
• Novo Nordisk Investigational Site — San Antonio, Texas, United States
• Novo Nordisk Investigational Site — Warrenton, Virginia, United States
• Novo Nordisk Investigational Site — Seattle, Washington, United States
• Novo Nordisk Investigational Site — Ebreichsdorf, Austria
• Novo Nordisk Investigational Site — Gratwein, Austria
• Novo Nordisk Investigational Site — Graz, Austria
• Novo Nordisk Investigational Site — Neunkirchen, Austria
• Novo Nordisk Investigational Site — Greenbrae, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.